Renal Calculi
Conditions
Brief summary
This study evaluates the safety and efficacy of the suctioning flexible ureteroscopy(SF-URS) with automatic control of renal pelvic pressure for the treatment of upper urinary calculi using a prospective, randomized design. Half of participants will receive suctioning flexible ureteroscopy with automatic control of renal pelvic pressure, while the other half participants will receive retrograde intrarenal surgery using the classic flexible ureteroscopy.
Detailed description
Retrograde intrarenal surgery using flexible ureteroscope has become the first-line treatment for renal calculi \< 3.0 cm and is recommended by the European Association of Urology due to its minimally-invasive nature and satisfactory result. However, high perfusion rate leads to renal pelvic pressure increase, resulting in absorption of liquid, bacteria, and endotoxin into blood, followed by short-term complications such as systemic inflammatory response syndrome(SIRS , 8.1%), sepsis (0-4.5%), renal pelvic and ureteral tumor spread, and long-term complication of renal function impairment. Currently the commonly used flexible ureteroscope sheath (ureteral access sheath, UAS) reduces the renal pelvic pressure to a certain extent, but still can not control and monitor the renal pelvic pressure to reduce the incidence of complications, which, limit the clinical application of ureteroscopy. Recently, the investigators present a novel technique of SF-URS with automatic control of renal pelvic pressure. In this study, transverse comparison is designed to evaluate the safety and efficacy of the suctioning flexible ureteroscopy with automatic control of renal pelvic pressure for the treatment of renal calculi.
Interventions
DEVICESF-URS with automatic control of RPP
A new F-URS monitoring and control of RPP using intelligent pressure control device
DEVICEconventional F-URS
Ureteroscopy will be conducted using the ureteral access sheath from Cook Medical to treat renal calculi.
Sponsors
The Affiliated Ganzhou Hospital of Nanchang University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Subject has provided informed consent and indicated a willingness to comply with study treatments * Subject has a diagnosis of renal stones according to computer tomography (CT) results * Subject is 18-75 yrs of age * Subject has a single stone \< 3 cm in size, or multiple stones \< 3 cm in cumulative size * Subject has a serum creatinine level within the normal range for the study center
Exclusion criteria
* The patient who do not agree with the intention of the clinical study. * Subject needs bilateral procedures within one-stage ureteroscopy * Subject has an active urinary tract infection (e.g., cystitis, prostatitis, urethritis, etc.) and severe hematuria * Subject has been diagnosed with a urethral stricture or bladder neck contracture * Subject has a disorder of the coagulation cascade system that would put the subject at risk for intraoperative or postoperative bleeding * Subject is unable to discontinue anticoagulant and antiplatelet therapy preoperatively (3-5 d) * Subject has other diseases and could not tolerate the endoscopic surgery * Subject has any kind of anatomic abnormality of the urinary system that might have an influence on the surgery * Subject has been diagnosed with hydronephrosis larger than 3 cm according to the B-scan ultrasonography examination
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| stone-free rate | 4 weeks post-operatively | Number of participants undergo novel or conventional F-URS surgeries without residual calculus/Total number of participants in each group \*100% |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| stone-free rate | One day post-operatively | Number of participants undergo novel or conventional F-URS surgeries without residual calculus/Total number of participants in each group \*100% |
| Complication rates | Within 4 weeks after surgery | Number of participants undergo novel or conventional F-URS surgeries suffer complications associated with the surgery (i.e. pain(NRS≥4), hematuria, T≥38℃, serum white blood cell≥12×〖10〗\^9/L ,serum white blood cell\<4×〖10〗\^9/L, perforation, etc.)/Total number of participants in each group \*100% |
Outcome results
None listed